TABLE 2.
Allelic distribution among clinical versus environmental V. vulnificus isolates
| Identifiera | Genotype distribution (%)b
|
|
|---|---|---|
| Clinical | Environmental | |
| 16S type | ||
| A | 27.3 | 80.0 |
| B | 66.7 | 8.6 |
| A+B | 6.0 | 11.4 |
| CPS allele | ||
| 1 | 63.6 | 20.0 |
| 2 | 36.4 | 71.4 |
| Allele absent | 0 | 8.6 |
| RAPD type | ||
| C | 66.7 | 8.6 |
| E | 33.3 | 91.4 |
| Profile | ||
| Clinical | 57.6 | 3.0 |
| Environmental | 27.3 | 60.0 |
| Atypical | 15.1 | 34.0 |
a
DNA polymorphisms were screened by PCR as described in Materials and Methods and are based on previously described assays for detection of alternate polymorphic sequences for DNA targets derived from 16S rRNA genes (27), the CPS operon (9), and RAPD (30) or for profiles of composite genotypes as described in the text.
b
The percentage of each genotype is shown for clinical versus environmental strains.